GLP-1 medications like Ozempic, Wegovy and Mounjaro have become something of a cultural lightning rod over the past few years ...
In a study published in JAMA Network Open in January 2025, which included more than 125,000 patients, nearly 65 percent of ...
An informational report based on publicly available materials from ReflexMD, Inc. - addressing how consumers evaluate GLP-1 ...
Jay Campbell, the author of Metabolic Awakening with GLP-1 Peptides, aims to reshape the narrative behind GLP-1 peptides, not ...
In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...
As use of GLP-1 medications surges, tools like Weight Loss Buddy emerge as critical infrastructure for sustaining ...
Experimenters hope to harness the powerful effects of medications such as Ozempic and Wegovy at doses smaller than those studied most.
Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...
As a physician who prescribes GLP-1 medications like Ozempic, Wegovy, semaglutide, and tirzepatide, I explain why increasing ...
Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...
This article was reviewed by Mike Bohl, MD. If you’ve been using a GLP-1 such as semaglutide, then you’ve likely experienced the powerful effects of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results